Syncope, commonly known as fainting, is a prevalent clinical problem that healthcare professionals encounter. It is a transient loss of consciousness due to inadequate blood flow to the brain. Understanding its complexities is crucial in providing effective patient care.
Syncope results from a temporary interruption in cerebral blood flow. The key mechanisms are usually neurocardiogenic, orthostatic hypotension, or cardiac. Neurocardiogenic syncope, the most common type, involves a reflex arc that causes bradycardia or vasodilation. Orthostatic hypotension is due to a failure of compensatory mechanisms upon standing. Cardiac syncope arises from arrhythmias or structural heart diseases.
A thorough history and physical examination are essential in the evaluation of syncope. Key features to consider include precipitating events, prodromal symptoms, and post-event recovery. Special attention should be given to cardiac history as it may suggest a more serious underlying condition.
While the diagnosis of syncope is clinical, further testing may be required to identify the underlying cause. This can include electrocardiography, echocardiography, tilt table testing, or even advanced cardiac imaging. The choice of diagnostic test should be guided by the clinical suspicion.
Management of syncope is primarily targeted at preventing recurrent episodes and treating underlying causes. This can range from lifestyle modifications for orthostatic hypotension, to pharmacological therapy for reflex syncope, to device therapy for cardiac syncope.
Syncope is a complex clinical entity that requires a comprehensive approach for effective management. Understanding its pathophysiology, conducting a thorough clinical evaluation, adopting an appropriate diagnostic approach, and implementing suitable management strategies are integral steps in providing optimal patient care.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation